At a glance
- Originator Novartis
- Class Analgesics; Anti-inflammatories
- Mechanism of Action Neurokinin 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Migraine; Nausea and vomiting; Pain
Most Recent Events
- 07 Sep 2001 No-Development-Reported for Emesis in United Kingdom (PO)
- 07 Sep 2001 No-Development-Reported for Migraine in United Kingdom (PO)
- 07 Sep 2001 No-Development-Reported for Pain in United Kingdom (PO)